Mural Oncology plc (MURA) Stock Analysis

Mural Oncology plc (MURA) is a publicly traded company in the HEALTHCARE sector. It trades at $2.04, carries a market capitalization of $35.38M. This page summarizes the public market data, fundamentals, and frequently asked questions for MURA, with GNG Research's proprietary safety, quality, and valuation analysis available to members.

Sector: HEALTHCARE - BIOTECHNOLOGY

Exchange: NASDAQ

Key Metrics

• Price: $2.04
• Market Cap: $35.38M
• EPS: $-6.93
• 52-Week High: $2.65
• 52-Week Low: $1.53

About Mural Oncology plc

None

GNG Research Analysis

GNG Research scores Mural Oncology plc (MURA) on three proprietary dimensions — a Safety score, a Quality score, and a Valuation score — alongside fair value estimates and buy-price targets for 5,000+ companies. These ratings are reserved for members. Read how the scores are calculated on our methodology page, or see GNG Research plans to unlock the full rating for MURA.

Frequently Asked Questions

Does MURA pay dividends?

Mural Oncology plc (MURA) does not currently pay a regular dividend.

What is MURA's market cap?

Mural Oncology plc (MURA) has a market capitalization of $35.38M with a current stock price of $2.04.